Dr Arthur William Nauman, MD | |
22 West Rd Ste 300, Towson, MD 21204-2310 | |
(410) 321-6100 | |
(443) 275-2465 |
Full Name | Dr Arthur William Nauman |
---|---|
Gender | Male |
Speciality | Obstetrics/gynecology |
Experience | 43 Years |
Location | 22 West Rd Ste 300, Towson, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083777379 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | D0031291 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Greater Baltimore Medical Center | Baltimore, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Capital Womens Care Llc | 4880582741 | 248 |
News Archive
Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, Eq, 1.4 mg/0.36 mg and 5.7 mg/1.4 mg Base. Actavis' ANDA product is a generic version of Orexo's Zubsolv, which is a partial opioid agonist indicated for the maintenance treatment of opioid dependence.
Healthways, Inc. today announced the organization is among the first in the nation to receive National Committee for Quality Assurance (NCQA) Wellness and Health Promotion (WHP) accreditation, making the company an early adopter.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
› Verified 3 days ago
Entity Name | Greater Baltimore Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891855763 PECOS PAC ID: 1759276975 Enrollment ID: O20040217000852 |
News Archive
Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, Eq, 1.4 mg/0.36 mg and 5.7 mg/1.4 mg Base. Actavis' ANDA product is a generic version of Orexo's Zubsolv, which is a partial opioid agonist indicated for the maintenance treatment of opioid dependence.
Healthways, Inc. today announced the organization is among the first in the nation to receive National Committee for Quality Assurance (NCQA) Wellness and Health Promotion (WHP) accreditation, making the company an early adopter.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
› Verified 3 days ago
Entity Name | Capital Womens Care Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679534069 PECOS PAC ID: 4880582741 Enrollment ID: O20050804000705 |
News Archive
Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, Eq, 1.4 mg/0.36 mg and 5.7 mg/1.4 mg Base. Actavis' ANDA product is a generic version of Orexo's Zubsolv, which is a partial opioid agonist indicated for the maintenance treatment of opioid dependence.
Healthways, Inc. today announced the organization is among the first in the nation to receive National Committee for Quality Assurance (NCQA) Wellness and Health Promotion (WHP) accreditation, making the company an early adopter.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Arthur William Nauman, MD 8110 Maple Lawn Blvd Ste 235, Fulton, MD 20759-2694 Ph: (301) 340-8339 | Dr Arthur William Nauman, MD 22 West Rd Ste 300, Towson, MD 21204-2310 Ph: (410) 321-6100 |
News Archive
Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, Eq, 1.4 mg/0.36 mg and 5.7 mg/1.4 mg Base. Actavis' ANDA product is a generic version of Orexo's Zubsolv, which is a partial opioid agonist indicated for the maintenance treatment of opioid dependence.
Healthways, Inc. today announced the organization is among the first in the nation to receive National Committee for Quality Assurance (NCQA) Wellness and Health Promotion (WHP) accreditation, making the company an early adopter.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
› Verified 3 days ago
Thelma S Asare, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 West Rd, Suite 404, Towson, MD 21204 Phone: 410-832-5511 Fax: 410-832-5560 | |
Dr. Marwan Ahmad Hajj, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6569 N Charles Street, Suite 710, Towson, MD 21204 Phone: 410-321-1313 Fax: 410-321-1366 | |
Mary Anne Facciolo, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7801 York Rd, Ste 133, Towson, MD 21204 Phone: 410-339-7447 Fax: 410-339-3684 | |
Dr. Giles Harrison Manley, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6904 N Charles St, Towson, MD 21204 Phone: 410-916-6712 Fax: 410-653-3200 | |
Monica A Buescher, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7801 York Rd, Suite 133, Towson, MD 21204 Phone: 410-339-7447 Fax: 410-339-3684 | |
Dr. Andrea C Fitzgerald, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7401 Osler Dr, Suite 205, Towson, MD 21204 Phone: 410-828-8077 Fax: 410-828-8077 |